Cargando…
Development and Characterization of Phage-Display-Derived Novel Human Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has resulted in an ongoing global pandemic crisis, caused by the life-threatening illness coronavirus disease 2019 (COVID-19). Thus, the rapid development of monoclonal antibodies (mAbs) to cope with COVID-19 is urgently necessary. In this...
Autores principales: | Kim, Ji Woong, Min, Sung Won, Lee, Jichul, Shin, Ha Gyeong, Choi, Hye Lim, Yang, Ha Rim, Lee, Ji Hyun, Cho, Yea Bin, Shim, Hyunbo, Lee, Sukmook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775448/ https://www.ncbi.nlm.nih.gov/pubmed/36552031 http://dx.doi.org/10.3390/biomedicines10123274 |
Ejemplares similares
-
Development and Characterization of Phage Display-Derived Monoclonal Antibodies to the S2 Domain of Spike Proteins of Wild-Type SARS-CoV-2 and Multiple Variants
por: Kim, Ji Woong, et al.
Publicado: (2023) -
Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy
por: Kim, Ji Woong, et al.
Publicado: (2021) -
Generation and Next-Generation Sequencing-Based Characterization of a Large Human Combinatorial Antibody Library
por: Choi, Hye Lim, et al.
Publicado: (2023) -
Correction: Kim et al. Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. Cells 2021, 10, 670
por: Kim, Ji Woong, et al.
Publicado: (2021) -
A novel bispecific antibody dual-targeting approach for enhanced neutralization against fast-evolving SARS-CoV-2 variants
por: Kim, Ji Woong, et al.
Publicado: (2023)